Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients.
Dekkers C, Smits H, Stölzl D, Spekhorst L, Knol E, van Wijk F, Harder I, Werfel T, Schmitt J, Kleinheinz A, Abraham S, Thijs J, Weidinger S, de Bruin-Weller M, Bakker D, Drylewicz J.
Dekkers C, et al. Among authors: thijs j.
Clin Exp Allergy. 2025 Jan;55(1):97-99. doi: 10.1111/cea.14585. Epub 2024 Oct 24.
Clin Exp Allergy. 2025.
PMID: 39449187
Free PMC article.
No abstract available.